Cordys Analytics is a company that developes an AI-powered software platform for early and improved detection of heart disease. By harnessing the power of advanced deep learning techniques, this software enhances the diagnostic process by identifying subtle patterns and abnormalities in electrocardiogram data (ECGs) that might not be easily discernible through traditional methods.
“We are thrilled to have these investors on board. By being part of their network and supported by this investment we are well-positioned to further expand our software platform and make it suitable for clinical use,” Cordys Analytics CEO John van den Berg.